Loading clinical trials...
Loading clinical trials...
A 2-WEEK, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, PHASE 2, MULTICENTER STUDY OF PF-04136309 IN SUBJECTS WITH OSTEOARTHRITIC PAIN OF THE KNEE
Conditions
Interventions
PF-04136309
Placebo
Locations
22
United States
University Clinical Research-DeLand, LLC
DeLand, Florida, United States
Arthritis & Rheumatic Care Center
South Miami, Florida, United States
Miami Research Associates
South Miami, Florida, United States
Diagnostic Imaging Centers
Overland Park, Kansas, United States
Vince and Associates Clinical Research
Overland Park, Kansas, United States
Commonwealth Biomedical Research, LLC
Madisonville, Kentucky, United States
Start Date
August 5, 2008
Primary Completion Date
November 27, 2008
Completion Date
November 27, 2008
Last Updated
July 13, 2021
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions